Regulatory effects of sulfur dioxide on the development of atherosclerotic lesions and vascular hydrogen sulfide in atherosclerotic rats

Atherosclerosis

Volumn 215, Issue 2, 2011, Pages 323-330

  Li, Wei ^a   Tang, Chaoshu ^b,c   Jin, Hongfang ^a   Du, Junbao ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Atherosclerosis; Hydrogen sulfide; Sulfur dioxide

Indexed keywords

ASPARTATE AMINOTRANSFERASE ISOENZYME 1; ASPARTATE AMINOTRANSFERASE ISOENZYME 2; CHOLESTEROL; COLECALCIFEROL; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTATHIONINE GAMMA LYASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROGEN SULFIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; NITRIC OXIDE; SULFUR DIOXIDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY; DISEASE COURSE; ELECTRODE; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MALE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASTRUCTURE;

ANIMALS; AORTA; ASPARTATE AMINOTRANSFERASES; ATHEROSCLEROSIS; CYSTATHIONINE GAMMA-LYASE; GLUTATHIONE PEROXIDASE; HYDROGEN SULFIDE; MALE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; SULFUR DIOXIDE; SUPEROXIDE DISMUTASE;

EID: 79953039549     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.12.037     Document Type: Article

References (30)

1. Radomski M.W., Salas E. Nitric oxide-biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis. Atherosclerosis 1995, 118:S69-S80.
2. Oemar B.S., Tschudi M.R., Godoy N., et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998, 97:2494-2498.
3. Juan S.H., Lee T.S., Tseng K.W., et al. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001, 104:1519-1525.
4. Orozco L.D., Kapturczak M.H., Barajas B., et al. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 2007, 100:1703-1711.
5. Wang Y., Zhao X., Jin H., et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2009, 29:173-179.
6. Stipanuk M.H. Metabolism of sulfur-containing amino acids. Annu Rev Nutr 1986, 6:179-209.
7. Du S.X., Jin H.F., Bu D.F., et al. Endogenously generated sulfur dioxide and its vasorelaxant effect in rats. Acta Pharmacol Sin 2008, 29:923-930.
8. Meng Z., Li J., Zhang Q., et al. Vasodilator effect of gaseous sulfur dioxide and regulation of its level by Ach in rat vascular tissues. Inhal Toxicol 2009, 21:1223-1228.
9. Jin H.F., Du S.X., Zhao X., et al. Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats. Acta Pharmacol Sin 2008, 29:1157-1166.
10. Sun Y., Tian Y., Prabha M., et al. Effects of sulfur dioxide on hypoxic pulmonary vascular structural remodeling. Lab Invest 2010, 90:68-82.
11. Liang Y., Liu D., Ochs T., et al. Endogenous sulfur dioxide protects against isoproterenol-induced myocardial injury and increases myocardial antioxidant capacity in rats. Lab Invest 2010, [Epub ahead of print].
12. Tang C.S., Li X.H., Du J.B. Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr Vasc Pharmacol 2006, 4:17-22.
13. Xiaohui L., Junbao D., Lin S., et al. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ J 2005, 69:1418-1424.
14. Wei H.L., Zhang C.Y., Jin H.F., Tang C.S., Du J.B. Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol Sin 2008, 29:670-676.
15. Wei H., Zhang R., Jin H., et al. Hydrogen sulfide attenuates hyperhomocysteinemia-induced cardiomyocytic endoplasmic reticulum stress in rats. Antioxid Redox Signal 2010, 12:1079-1091.
16. Stipanuk M.H., Beck P.W. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 1982, 206:267-277.
17. Ali M.Y., Ping C.Y., Mok Y.Y., et al. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?. Br J Pharmacol 2006, 149:625-634.
18. Qingyou Z., Junbao D., Weijin Z., et al. Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem Biophys Res Commun 2004, 317:30-37.
19. Jin H.F., Du J.B., Li X.H., et al. Interaction between hydrogen sulfide/cystathionine gamma-lyase and carbon monoxide/heme oxygenase pathways in aortic smooth muscle cells. Acta Pharmacol Sin 2006, 27:1561-1566.
20. Balazy M., Abu-Yousef I.A., Harpp D.N., Park J. Identification of carbonyl sulfide and sulfur dioxide in porcine coronary artery by gas chromatography/mass spectrometry, possible relevance to EDHF. Biochem Biophys Res Commun 2003, 311:728-734.
21. Shapiro R. Genetic effects of bisulfite (sulfur dioxide). Mutat Res 1977, 39:149-175.
22. Li J., Meng Z. The role of sulfur dioxide as an endogenous gaseous vasoactive factor in synergy with nitric oxide. Nitric Oxide Biol Chem 2009, 20:166-174.
23. Li J., Li R., Meng Z. Sulfur dioxide upregulates the aortic nitric oxide pathway in rats. Eur J Pharmacol 2010, 645:143-150.
24. Huang Z.Y., Yang P.Y., Almofti M.R., et al. Comparative analysis of the proteome of left ventricular heart of arteriosclerosis in rat. Life Sci 2004, 75:3103-3115.
25. Meng Z., Geng H., Bai J., Yan G. Blood pressure of rats lowered by sulfur dioxide and its derivatives. Inhal Toxicol 2003, 15:951-959.
26. Meng Z., Li Y., Li J. Vasodilatation of sulfur dioxide derivatives and signal transduction. Arch Biochem Biophys 2007, 467:291-296.
27. 2+ channels. Eur J Pharmacol 2009, 602:117-123.
28. Collin M., Thiemermann C. Hydrogen sulfide and sulfite: novel mediators in the pathophysiology of shock and inflammation. Shock 2005, 24:595-596.
29. Mitsuhashi H., Yamashita S., Ikeuchi H., et al. Oxidative stress-dependent conversion of hydrogen sulfide to sulfite by activated neutrophils. Shock 2005, 24:529-534.
30. Naruse K., Shimizu K., Muramatsu M., et al. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta PGH2 does not contribute to impaired endothelium-dependent relaxation. Arterioscler Thromb 1994, 14:746-752.